Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy

Molecular Immunology

Volumn 62, Issue 1, 2014, Pages 159-168

  Chowdhury, Imran Hussain ^a   Ahmed, Albin Mostaque ^b   Choudhuri, Subhadip ^a   Sen, Aditi ^a   Hazra, Avijit ^a   Pal, Nishith Kumar ^a   Bhattacharya, Basudev ^a   Bahar, Bojlul ^b  

^a INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cytokine; Immunity; Inflammation; Mycobacteria; Tuberculosis

Indexed keywords

CYCLOSERINE; CYTOKINE; ETHAMBUTOL; ETHIONAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIAL LOAD; BODY MASS; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG CAVITATION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPUTUM ANALYSIS; TREATMENT RESPONSE; BLOOD; CASE CONTROL STUDY; PROGNOSIS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

ADULT; ANTITUBERCULAR AGENTS; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-6; MALE; PROGNOSIS; TRANSFORMING GROWTH FACTOR BETA1; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904360841     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.002     Document Type: Article

References (27)

1. Ellis S.M. The spectrum of tuberculosis and non-tuberculous mycobacterial infection. Eur. Radiol. 2004, 14:E34-E42.
2. Grange J.M. The mystery of the mycobacterial 'persister'. Tubercle Lung Dis. 1992, 73:249-251.
3. Cooper A.M., Khader S.A. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev. 2008, 226:191-204.
4. Ameglio F., Casarini M., Capoluongo E., Mattia P., Puglisi G., Giosue S. Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis. Int. J. Tuberc. Lung Dis. 2005, 9:98-104.
5. Johnson B.J., McMurray D.N. Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes. Infect. Immun. 1994, 62:1444-1450.
6. Munk M.E., Emoto M. Functions of T-cell subsets and cytokines in mycobacterial infections. Eur. Respir. J. Suppl. 1995, 20:668-675.
7. Boom W.H., Canaday D.H., Fulton S.A., Gehring A.J., Rojas R.E., Torres M. Human immunity to M. tuberculosis: T cell subsets and antigen processing. Tuberculosis (Edinb.) 2003, 83:98-106.
8. Raja A. Immunology of tuberculosis. Indian J. Med. Res. 2004, 120:213-232.
9. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994, 84:4008-4027.
10. Cooper A.M., Mayer-Barber K.D., Sher A. Role of innate cytokines in mycobacterial infection. Mucosal Immunol. 2011, 4:252-260.
11. Denis M. Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol. Clin. Exp. Immunol. 1991, 84:200-206.
12. Conesa-Botella A., Meintjes G., Coussens A.K., van der Plas H., Goliath R., Schutz C., Moreno-Reyes R., Mehta M., Martineau A.R., Wilkinson R.J., Colebunders R., Wilkinson K.A. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV tuberculosis immune reconstitution inflammatory syndrome. Clin. Infect. Dis. 2012, 55:1004-1011.
13. Sharma S., Bose M. Role of cytokines in immune response to pulmonary tuberculosis. Asian Pac. J. Allergy Immunol. 2001, 19:213-219.
14. Chowdhury I.H., Sen A., Bahar B., Hazra A., Chakraborty U., Choudhuri S., Goswami A., Pal N.K., Bhattacharya B. A molecular approach to identification and profiling of first-line drug resistant mycobacteria from sputum of pulmonary tuberculosis patients. J. Clin. Microbiol. 2012, 50:2082-2084.
15. van Crevel R., Ottenhoff T.H., van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 2002, 15:294-309.
16. Nagabhushanam V., Solache A., Ting L.M., Escaron C.J., Zhang J.Y., Ernst J.D. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma. J. Immunol. 2003, 171:4750-4757.
17. Martinez A.N., Mehra S., Kaushal D. Role of interleukin 6 in innate immunity to Mycobacterium tuberculosis infection. J. Infect. Dis. 2013, 207:1253-1261.
18. Saunders B.M., Frank A.A., Orme I.M., Cooper A.M. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect. Immun. 2000, 68:3322-3326.
19. Flynn J.L., Chan J. Immunology of tuberculosis. Annu. Rev. Immunol. 2001, 19:93-129.
20. Zuñiga J., Torres-García D., Santos-Mendoza T., Rodriguez-Reyna T.S., Granados J., Yunis E.J. Cellular and humoral mechanisms involved in the control of tuberculosis. Clin. Dev. Immunol. 2012, 2012:193-923.
21. Aksu G., Tirpan C., Cavuşoǧlu C., Soydan S., Altare F., Casanova J.L., Kutukculer N. Mycobacterium fortuitum-chelonae complex infection in a child with complete interleukin-12 receptor beta 1 deficiency. Pediatr. Infect. Dis. J. 2001, 20:551-553.
22. Casanova J.L. Mendelian susceptibility to mycobacterial infection in man. Swiss Med. Wkly. 2001, 131:445-454.
23. Hsieh S.M., Hung C.C., Chen M.Y., Sheng W.H., Chang S.C. Dynamics of plasma cytokine levels in patients with advanced HIV infection and active tuberculosis: implications for early recognition of patients with poor response to anti-tuberculosis treatment. AIDS 1999, 13:935-941.
24. Riou C., Perez Peixoto B., Roberts L., Ronacher K., Walzl G., Manca C., Rustomjee R., Mthiyane T., Fallows D., Gray C.M., Kaplan G. Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis. PLoS One 2012, 7:e36886.
25. Schaible U.E., Kaufmann S.H. Malnutrition and infection: complex mechanisms and global impacts. PLoS Med. 2007, 4:e115.
26. Medzhitov R. Septic shock: on the importance of being tolerant. Immunity 2013, 39:799-800.
27. Keicho N., Matsushita I., Tanaka T., Shimbo T., Hang N.T., Sakurada S., Kobayashi N., Hijikata M., Thuong P.H., Lien L.T. Circulating levels of adiponectin, leptin, fetuin-A and retinol-binding protein in patients with tuberculosis: markers of metabolism and inflammation. PLoS One 2012, 7:e38703.